Baseline data of 39 patients chronically infected with HCV, genotype 1, divided in groups with either SVR or non-SVR following pegylated interferon/ribavirin treatment.

The data is shown in absolute numbers and percent of the total in the group. None of the baseline data was significant predictors of pegylated interferon/ribavirin treatment outcome in this cohort.*only patients with a biopsy were included. SVR = sustained virologic response, non-SVR = non sustained virologic response.